Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Lille
Clinical trial register · France

Clinical Trials in Lille, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Paris 38 Lyon 27 Montpellier 21 Marseille 19 Lille 19
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Lille138 Janssen Research & Development, LLC43 Hoffmann-La Roche39 AstraZeneca36 Assistance Publique - Hôpitaux de Paris34 Clear sponsor filter
Site location
Paris38 Lyon27 Montpellier21 Marseille19 Lille19
All 66 locations
Target enrolment
to

Trials with a site in Lille

19 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
Eli Lilly and Company
Phase 1
215
Lille, Paris
2026-05-28
Recruiting
Eli Lilly and Company
Phase 3
150
Bron, Corbeil-Essonnes, Lille, Marseille, Paris, Toulouse
2026-01-12
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Angers, Bordeaux, Brest, Caen, Lille, Lyon Cedex08, Marseille, Nîmes
2025-12-12
Recruiting
Eli Lilly and Company
Phase 3
1,630
Angers, Bayonne, Besançon, Bordeaux, Brest, Lille, Limoges, Lyon Cedex08
2025-10-22
Recruiting
Eli Lilly and Company
Phase 3
4,500
Amiens, Angers, Besançon, Clichy, Dijon, La Roche-sur-Yon, Lille, Limoges
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Dijon, Epagny Metz-Tessy, La Tronche, Lille, Lyon, Nantes, Nice, Paris
2025-09-02
Active, closed
Eli Lilly and Company
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2024-10-25
Recruiting
Eli Lilly and Company
Phase 3
300
Angers, Bron, Lille, Marseille, Paris, Toulouse
2024-06-03
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bobigny, Bron, Chambray-lès-Tours, Compiègne, Dijon, Le Coudray, Lille, Lyon
2024-03-05
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Lille, Lyon, Marseille, Strasbourg, Villejuif
2024-03-05
Recruiting
Eli Lilly and Company
Phase 3
1,264
Avignon, Bron, Lille, Lyon Cedex08, Nice, Paris, Pessac, Poitiers
2023-12-21
By invitation
Eli Lilly and Company
Phase 3
333
Romans-sur-Isère, Lille, Nantes, Toulouse
2023-03-09
Active, closed
Eli Lilly and Company
Phase 3
312
Amiens, Bordeaux, Créteil, Lille, Marseille, Paris
2020-11-25
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amiens, Chambray-lès-Tours, Lille, Montpellier, Neuilly-sur-Seine, Nice, Paris, Pau
2018-07-18
Active, closed
Eli Lilly and Company
Phase 1
223
Paris, Lille, Villejuif
2016-11-21
Active, closed
Eli Lilly and Company
Phase 1
100
Lille, Montpellier, Toulouse
2016-11-14
Active, closed
Eli Lilly and Company
Phase 2
309
Lyon, Bordeaux, Besançon, Lille, Montpellier, Nice, Villejuif
2016-05-19
Active, closed
Eli Lilly and Company
Phase 3
545
Montpellier, La Tronche, Lille, Poitiers, Paris
2015-05-06
Active, closed
Eli Lilly and Company
Phase 3
453
Bron, Dijon, Grenoble, Lille, Marseille, Poitiers, Rennes, Saint-Brieuc
2014-10-03
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 October 2026. https://priyalifescience.com/clinical-trials-france/city/lille

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Lille that also match the filters currently applied.

How many clinical trials are recruiting in Lille?

8 of the 19 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Lille), 19 studies
PhaseStudiesRecruitingShare
Phase 313768.4%
Phase 14121.1%
Phase 22010.5%

Most active sponsors

Lead sponsors with the most studies (Lille)
Lead sponsorStudiesRecruiting
Eli Lilly and Company198
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.